Literature DB >> 10095085

Dynamic expression of SEK1 suggests multiple roles of the gene during embryogenesis and in adult brain of mice.

J K Lee1, W S Hwang, Y D Lee, P L Han.   

Abstract

Stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK), a member of the MAP kinase (MAPK) superfamily, plays a key role in a variety of cellular processes. It is well established that SAPK/JNK activation is controlled by SEK1/MKK4, an up-stream MAP kinase kinase. To gain insight into the role of SEK1 during embryonic development and in adult life, we examined the temporal and spatial patterns of sek1 expression in mice by using in situ hybridization and immunohistochemical study. Dynamic changes of sek1 expression were observed during embryogenesis. Strong sek1 expression was detected in most of the central nervous system and in liver and thymus during early stages of development. While the sek1 expression in nervous system increases over time, expression in fetal liver and thymus gradually decreases as embryogenesis proceeds. High level of the sek1 expression in the central nervous system was persisted throughout postnatal development and remained at a stable level in adult brain. These observations provide an anatomical basis for the vital role(s) of SEK1 in development, for example, in hepatogenesis and/or neurogenesis. Although SEK1 was widely expressed in adult brain, more strong expression of the sek1 was observed at layers 2 and 6 in cerebral cortex, in Purkinje cells of cerebellum, and also in hypothalamic nuclei. The strongest expression of the sek1 was found in the CA3 region of hippocampus, the region being highly vulnerable to exitotoxicity-induced apoptosis in kainate-treated animal models. Interestingly, SEK1 was localized not only in cytoplasm but in dendrites and/or in nucleus of neurons depending on the regions of adult mouse brain. Taken together, these results suggest multiple roles of the SEK1 during embryogenesis and in adult brain. Copyright 1999 Elsevier Science B. V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095085     DOI: 10.1016/s0169-328x(99)00035-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Co-induction of alphaB-crystallin and MAPKAPK-2 in astrocytes in the penumbra after transient focal cerebral ischemia.

Authors:  Chun-Shu Piao; Seung-Woo Kim; Jung-Bin Kim; Ja-Kyeong Lee
Journal:  Exp Brain Res       Date:  2005-04-26       Impact factor: 1.972

2.  The soft underbelly of tumor cells.

Authors:  Yufeng Shi; S Kyun Lim; Luis F Parada
Journal:  Cell Res       Date:  2014-05-30       Impact factor: 25.617

3.  The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain.

Authors:  Seung-Woo Kim; Chae-Moon Lim; Hye-Kyung Lee; Ja-Kyeong Lee
Journal:  Anat Cell Biol       Date:  2011-12-30

4.  NF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamide.

Authors:  Arkady Torchinsky; Lucy Lishanski; Orit Wolstein; Jeanne Shepshelovich; Hasida Orenstein; Shoshana Savion; Zeev Zaslavsky; Howard Carp; Alexander Brill; Rivka Dikstein; Vladimir Toder; Amos Fein
Journal:  BMC Dev Biol       Date:  2002-02-05       Impact factor: 1.978

5.  Assessing developmental roles of MKK4 and MKK7 in vitro.

Authors:  Jingcai Wang; Ying Xia
Journal:  Commun Integr Biol       Date:  2012-07-01

6.  Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.

Authors:  Zhou Xing; Minling Zeng; Huixian Hu; Hui Zhang; Zhuofang Hao; Yuesheng Long; Shengqiang Chen; Hang Su; Zhongmin Yuan; Meng Xu; Jingqi Chen
Journal:  Oncotarget       Date:  2016-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.